Kelly Krajnik
Kelly Krajnik is Director, Head of MedTech at Broadview Ventures, managing its MedTech practice. She has 20 years of experience in early-stage technology and previously worked at Mayo Clinic Ventures.
What Kelly can write
Career
- Mayo Clinic · developing gene expression microarray protocols
- Mayo Clinic · managed one of Mayo’s four Institutional Review Boards
- Mayo Clinic Ventures · Senior Director of Business Development
- Broadview Ventures · Director, Head of MedTechNow
Investments named in public bios
Focus
Education
Also at Broadview Ventures
Partners like Kelly
At firms with a similar stage, sector and check size.
Alert me when Broadview Ventures is active
One email when Kelly's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Kelly Krajnik?
Kelly Krajnik is Director, Head of MedTech at Broadview Ventures, managing its MedTech practice. She has 20 years of experience in early-stage technology and previously worked at Mayo Clinic Ventures.
How much does Kelly Krajnik invest?
Broadview Ventures has not reported a check size. It invests at seed, series a.
How do I pitch Kelly Krajnik?
A warm intro from a founder Broadview Ventures backed works best. A short LinkedIn note with one line on traction is the next best route.
What did Kelly Krajnik do before Broadview Ventures?
developing gene expression microarray protocols at Mayo Clinic; managed one of Mayo’s four Institutional Review Boards at Mayo Clinic; Senior Director of Business Development at Mayo Clinic Ventures.
Last updated 2026-10-15. Is this you? Ask for a correction.